C12N 2740/12023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2740/12023 (Virus like particles [vlp]) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 7
- Assignees
- 2
- Inventors
- 12
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 2 | 2 |
By publication year.
Recent patents
- VLP-based monovalent ebola vaccines and methods of making and using same30 Sep 2025US 12,427,190 B2Children's Hospital Medical Center
- VLP-based bivalent Ebola vaccines and methods of making and using same22 Apr 2025US 12,280,100 B2Children's Hospital Medical Center
- VLP-based bivalent ebola vaccines and methods of making and using same6 Feb 2024US 11,890,337 B2Children's Hospital Medical Center
- VLP-based bivalent Ebola vaccines and methods of making and using same28 Sep 2021US 11,129,886 B2Children's Hospital Medical Center
- Modular betaretrovirus receptor attachment and cell entry proteins8 May 2025US 2025/0144238 A1
- Compositions and methods for efficient in vivo delivery1 May 2025US 2025/0136950 A1Nvelop Therapeutics, Inc.
- Vlp-based bivalent ebola vaccines and methods of making and using same25 Apr 2024US 2024/0131141 A1Children's Hospital Medical Center
- Vlp-based bivalent ebola vaccines and methods of making and using same16 Dec 2021US 2021/0386849 A1Children's Hospital Medical Center
- Vlp-based bivalent ebola vaccines and methods of making and using same19 Mar 2020US 2020/0085936 A1Children's Hospital Medical Center
Most cited
By later US patents